The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Texas AG Ken Paxton investigates grocery chains for spraying organic produce with pesticides, aiming to protect consumer ...
NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and ...
Scott Adams, whose popular comic strip “Dilbert” captured the frustration of beleaguered, white-collar cubicle workers and satirized the ridiculousness of modern office culture until he was abruptly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback